Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9Gynecologic 5Gastrointestinal 4Thoracic 3Head & Neck 3Tumor-Agnostic 2Genitourinary 2Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Lymphoma, Follicular 1Intellectual Disability 1

Interventions

Rituximab 1401Cyclophosphamide 1305Vincristine 668Doxorubicin 587Etoposide 527Prednisone 510Cytarabine 486fludarabine 469Methotrexate 445Dexamethasone 413fludarabine phosphate 400Lenalidomide 356Filgrastim 343Bendamustine Hydrochloride 282Radiotherapy 267venetoclax 260ibrutinib 258obinutuzumab 235Peripheral Blood Stem Cell Transplantation 234Melphalan 230Granulocyte Colony-Stimulating Factor 215Bortezomib 204Gemcitabine 202Busulfan 188Whole-Body Irradiation 187Mycophenolic Acid 175Tacrolimus 165Specimen Handling 162Magnetic Resonance Spectroscopy 155Calcium Dobesilate 150

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Population Groups × Lymphoid × Clear all
NCT05167929 2022-03-09

Self-determination Enhancement Group for Adults With Mild Intellectual Disability and Their Caregivers in Hong Kong

Chinese University of Hong Kong

Phase NA Unknown
120 enrolled
Lymphoid

Lymphoma, Follicular, Intellectual Disability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡